Stay updated on Psilocybin for Depression/Anxiety in Parkinson's Disease Clinical Trial

Sign up to get notified when there's something new on the Psilocybin for Depression/Anxiety in Parkinson's Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Psilocybin for Depression/Anxiety in Parkinson's Disease Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now displays the completed clinical study record for a comparison of risankizumab and apremilast for moderate plaque psoriasis, including study design, outcomes, locations, and supporting documents.
    Difference
    78%
    Check dated 2026-11-08T11:39:50.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0. The study record remains unavailable behind a 403 Forbidden message.
    Difference
    0.2%
    Check dated 2026-11-01T12:28:44.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition. It appears above the unavailable study record.
    Difference
    1%
    Check dated 2026-10-25T12:36:47.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now identifies the site revision as v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T13:39:07.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden message and a Home link; the site revision changed from v3.7.0 to v3.7.1.
    Difference
    0.6%
    Check dated 2026-10-11T13:31:25.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The 403 error page and its Home link are no longer displayed; the study record content is not visible.
    Difference
    0.5%
    Check dated 2026-10-04T13:51:02.000Z thumbnail image

Stay in the know with updates to Psilocybin for Depression/Anxiety in Parkinson's Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Psilocybin for Depression/Anxiety in Parkinson's Disease Clinical Trial page.